KORU Medical partners for Phase III trial in rare kidney disorder
Systems (NASDAQ: KRMD), a medical technology firm with a market capitalization of $194 million, announced a partnership with a global pharmaceutical manufacturer to conduct a Phase III clinical trial.
Illinois Policy54m
What you need to know about whether Chicago Teachers Union will strike in April
The Chicago Teachers Union and Chicago Public Schools entered the “fact finding” phase of negotiations in January 2025. Here’s what that means, whether Chicago students might be out of class, when and ...
When is the Champions League knockout play-offs draw? How does it work?
League phase tableThe top-eight teams from the league phase earned a bye to the last 16 as seeded teams, but what happens to the other 16 teams who are in the knockout round play-offs? Everything is ...
glasgowtimes29m
How much have Rangers earned in league phase of Europa League?
Rangers have banked £9m for their efforts in the league phase of the Europa League. The Ibrox club achieved the figure after earning numerous performance bonuses on top of participation and ...